Today: 16 April 2026
Coherent stock price slips after-hours as Bain affiliate exits stake in $2.22 billion block sale
13 February 2026
2 mins read

Coherent stock price slips after-hours as Bain affiliate exits stake in $2.22 billion block sale

New York, Feb 12, 2026, 17:50 EST — After-hours

  • Coherent dropped roughly 3% in late trade following a filing that showed a key shareholder had exited.
  • An affiliate of Bain Capital reported the sale of 9.44 million shares through a Rule 144 block trade, leaving it with zero shares now.
  • Friday, traders are eyeing U.S. inflation numbers and watching to see if additional stock supply hits the market.

Coherent Corp (COHR) shares fell after hours Thursday, as new filings revealed a Bain Capital affiliate unloaded its entire stake in the photonics manufacturer through a multibillion-dollar block sale.

The news drops just as high-growth hardware stocks are on edge. Large investors cashing out tends to put a lid on rallies, since more shares hit the market—even if the company story hasn’t changed.

BCPE Watson (DE) BML, LP unloaded 9,437,238 Coherent shares in a Feb. 9 block trade, a Schedule 13D/A filing showed. The sale, done under Rule 144, priced at $235.58 apiece and totaled $2,223,224,528.04. Following the transaction, the filing notes, the group no longer beneficially owns any Coherent common stock. It also plans to distribute 338,608 shares to select members or partners for charitable giving.

Coherent slipped roughly 3.3% to $216.10, bouncing between $209.75 and $229.60 today. The stock is still sitting well above its 52-week low at $54.00, though it’s pulled back from a high of $239.17. Among peers, Lumentum edged up 1.7%, IPG Photonics soared nearly 35%, while Applied Optoelectronics tumbled 9%.

U.S. stocks took a steep hit Thursday—the Nasdaq dropped roughly 2%—as traders grew wary before Friday’s inflation numbers and weighed whether big bets on AI are really paying off anytime soon.

Block trades—big, negotiated sales usually run through banks—let sellers move large positions fast, often at prices below the prior close. Rule 144, an SEC regulation, sets out how restricted or “control” stock can be sold; filings under it often signal or document major holders exiting.

In a separate Thursday filing, Coherent CFO Sherri Luther outlined plans to sell 4,000 shares, totaling roughly $894,760 in market value, with Morgan Stanley Smith Barney handling the trade. The document gave Nov. 13, 2025 as the adoption date for her Rule 10b5-1 plan—a preset schedule for insider share sales.

In a separate announcement, Coherent reported that six of its products picked up honors in the 2026 Lightwave Innovation Reviews, with a spotlight on optical networking gear and transceivers used near data centers and communications infrastructure. “These awards reflect the strength and depth of our technology,” Chief Technology Officer Julie Eng said in the statement. markets.businessinsider.com

There’s a lingering risk here: selling might not wrap up cleanly after a single exit. Bain’s affiliate may show zero ownership now, but investors are watching closely for any hints of more shares hitting the market—whether that’s from further insider sales, distribution-driven supply, or signals of weaker demand, any of which could force another reset in expectations.

Friday brings the U.S. inflation report, with investors also watching for more details on the block trade’s settlement and what happens with the shares afterward.

Stock Market Today

  • NuScale Power Share Price Overvalued by 47% Based on DCF Analysis, Faces Valuation Challenges
    April 15, 2026, 9:50 PM EDT. NuScale Power (SMR) shares closed at $11.71, down 19.2% over one year but up 18.8% in the past week. Recent Discounted Cash Flow (DCF) analysis estimates intrinsic value at $7.96, indicating shares are overvalued by 47.1%. The company reported a trailing twelve-month free cash flow loss of $460.39 million with projections turning positive by 2030. NuScale Power scores 1 out of 6 on valuation checks, reflecting concerns about its fundamentals versus market price. Investors remain cautious amid volatility and mixed returns, weighing NuScale's potential long-term growth against current premium valuations.

Latest article

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

16 April 2026
Norse Atlantic Airways has canceled all planned summer flights from Los Angeles to London Gatwick, Paris, and Rome, citing surging jet fuel costs. The airline launched a $110 million rights issue, secured a $70 million bridge loan, and withdrew its 2026 outlook. Routes disappeared from booking systems on April 14. Norse had been the only scheduled operator on the Gatwick-Los Angeles route.
S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

16 April 2026
The S&P 500 closed at a record 7,022.95 and the Nasdaq at 24,016.02 on Wednesday, erasing losses from the March selloff tied to the Feb. 28 conflict. Bank of America reported $8.6 billion in first-quarter net income, up 17%, while Morgan Stanley posted record revenue. Talks between Washington and Tehran raised hopes for easing oil supply fears, but Brent crude stayed elevated at $94.93 a barrel.
Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

16 April 2026
China is considering export restrictions on advanced solar-manufacturing equipment to the U.S., potentially affecting Tesla’s plans for new factories, sources told Reuters. Tesla aims to buy $2.9 billion in solar-panel equipment from China and expand U.S. solar production. China produces over 80% of global solar panel components. No final decision has been made, and consultations remain preliminary.
Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

15 April 2026
Hims & Hers Health shares rose 14% to $24.29 after the FDA said it will review restrictions on several peptides, including BPC-157 and TB-500. The agency set a July advisory meeting and will remove some peptides from its safety-risk list within a week. Hims, which acquired a California peptide facility last year, reported $2.35 billion in 2025 revenue and 2.511 million subscribers.
Standard Chartered taps B2C2 to speed “fiat-to-crypto” transfers for big investors
Previous Story

Standard Chartered taps B2C2 to speed “fiat-to-crypto” transfers for big investors

Corsair Gaming stock (CRSR) jumps after hours on Q4 results, buyback and 2026 outlook
Next Story

Corsair Gaming stock (CRSR) jumps after hours on Q4 results, buyback and 2026 outlook

Go toTop